When is a booster dose of rabies vaccine (Human Diploid Cell Vaccine (HDCV) or Purified Chick Embryo Cell Vaccine (PCECV)) recommended for reexposure to a dog bite in a previously vaccinated individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabies Vaccine Booster Protocol for Previously Vaccinated Individuals with Dog Bite Reexposure

For previously vaccinated individuals who are reexposed to a dog bite, two doses of rabies vaccine (HDCV or PCECV) should be administered: one immediately upon presentation and the second dose 3 days later, without rabies immunoglobulin. 1

Definition of Previously Vaccinated Individual

A previously vaccinated person is defined as someone who has:

  • Received a complete pre-exposure or post-exposure prophylaxis regimen of HDCV, PCECV, or RVA 1, 2
  • Documented rabies virus neutralizing antibody titer from previous vaccination 1

Booster Protocol for Reexposure

Vaccination Schedule

  • Administer two 1.0 mL doses of rabies vaccine (HDCV or PCECV) intramuscularly in the deltoid muscle 1, 3
    • First dose: Immediately upon presentation (day 0)
    • Second dose: 3 days after the first dose (day 3)

Important Considerations

  • Rabies immunoglobulin (RIG) should NOT be administered to previously vaccinated individuals 1, 4, 3
  • RIG may inhibit the strength or rapidity of the expected anamnestic immune response 1
  • Previously vaccinated individuals develop a rapid anamnestic antibody response following booster vaccination 1, 5

Wound Management

  • All post-exposure treatment should begin with immediate thorough cleansing of all wounds with soap and water 6, 3
  • If available, a virucidal agent such as povidone-iodine solution should be used to irrigate the wounds 3
  • Consider tetanus prophylaxis as appropriate 6

Special Considerations

Immunocompromised Patients

  • Immunosuppressed individuals may have suboptimal response to vaccination 1, 4
  • Consultation with public health officials is recommended when treating immunosuppressed previously vaccinated individuals 1, 4
  • Antibody titers should be checked after vaccination in immunosuppressed individuals 4, 2

Antibody Testing

  • Determining rabies virus neutralizing antibody titer before administering boosters to previously vaccinated persons is unnecessary and inappropriate 1
  • Testing would delay treatment and no specific "protective" titer is definitively established 1

Common Pitfalls to Avoid

  • Administering rabies immunoglobulin: Previously vaccinated individuals should NOT receive RIG as it may suppress the anamnestic response 1, 3
  • Delaying treatment: Do not delay administration of booster doses for antibody testing 1
  • Inadequate wound care: Thorough wound cleansing is essential and markedly reduces the likelihood of rabies 6
  • Using the wrong vaccination schedule: Do not use the full 4-5 dose schedule intended for previously unvaccinated individuals 3, 7
  • Incorrect administration site: The deltoid area is the only acceptable site of vaccination for adults and older children 3

Effectiveness of Booster Doses

  • Studies show that booster doses produce remarkable antibody responses in previously vaccinated individuals 8
  • A single intradermal booster dose can effectively stimulate a mature and sustained antibody response 5
  • Even when antibody levels have declined below protective levels, booster vaccination rapidly restores immunity 9, 10

References

Guideline

Rabies Vaccine Protocol for Previously Vaccinated Individuals

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pre-Exposure Prophylaxis for Rabies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Recommended Interval for Anti-Rabies Vaccine Booster Doses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.